Δ9-四氢大麻酚与大麻二酚对眼压的差异调控
该研究在小鼠中测试局部应用Δ9-四氢大麻酚(THC)和大麻二酚(CBD)对眼压的影响。单次局部应用THC使雄性小鼠眼压显著降低约28%并持续8小时,该效应由CB1和GPR18受体共同激活介导且存在性别差异。CBD本身对眼压有双向作用,并可阻止THC降低眼压。
要点
- 单次局部THC使雄性小鼠眼压降低约28%,持续8小时。
- THC降压效应由CB1和GPR18受体共同激活介导,雄性表达更高。
- CBD对眼压有双向作用,且可阻止THC的降眼压效应。
核心结论
- THC通过激活CB1和GPR18两种受体降低眼压,且效应存在性别依赖性。
- CBD对眼压有双向作用,并可干扰THC的降眼压效果。
研究设计与样本
- 在活体小鼠中局部应用THC和CBD,采用眼压计测量眼压并检测mRNA水平。
- 通过脂质分析检测CBD处理后的脂质组学变化。
主要发现
- 单次局部应用THC使雄性小鼠眼压显著降低约28%,持续8小时。
- THC降眼压效应由CB1和GPR18受体共同激活介导。
- THC降眼压效应在雄性小鼠中更强,且雄性CB1和GPR18的mRNA水平更高。
- CBD对眼压有双向作用,其一涉及拮抗紧张性信号传导。
- CBD可阻止THC降低眼压。
临床怎么用
- 提示THC降眼压作用涉及CB1和GPR18双受体机制且存在性别差异。
- CBD可能干扰THC的降眼压效果,联合使用需谨慎评估。
局限性
- 研究仅在小鼠中进行,结论外推到人需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: It has been known for nearly 50 years that cannabis and the psychoactive constituent Δ9-tetrahydrocannabinol (THC) reduce intraocular pressure (IOP). Elevated IOP remains the chief hallmark and therapeutic target for glaucoma, a major cause of blindness. THC likely acts via one of the known cannabinoid-related receptors (CB1, CB2, GPR18, GPR119, GPR55) but this has never been determined explicitly. Cannabidiol (CBD) is a second major constituent of cannabis that has been found to be without effect on IOP in most studies. METHODS: Effects of topically applied THC and CBD were tested in living mice by using tonometry and measurements of mRNA levels. In addition the lipidomic consequences of CBD treatment were tested by using lipid analysis. RESULTS: We now report that a single topical application of THC lowered IOP substantially (∼28%) for 8 hours in male mice. This effect is due to combined activation of CB1 and GPR18 receptors each of which has been shown to lower ocular pressure when activated. We also found that the effect was sex-dependent, being stronger in male mice, and that mRNA levels of CB1 and GPR18 were higher in males. Far from inactive, CBD was found to have two opposing effects on ocular pressure, one of which involved antagonism of tonic signaling. CBD prevents THC from lowering ocular pressure. CONCLUSIONS: We conclude that THC lowers IOP by activating two receptors-CB1 and GPR18-but in a sex-dependent manner. CBD, contrary to expectation, has two opposing effects on IOP and can interfere with the effects of THC.
引用
- Miller S, Daily L, Leishman E, et al. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Invest Ophthalmol Vis Sci. 2018. PMID: 30550613. doi:10.1167/iovs.18-24838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。